Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands

The Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA) demonstrated the efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) in preventing vaccine-type community-acquired pneumonia and vaccine-type invasive pneumococcal disease in elderly subjects. We examined the cost-effect...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Eur Respir J
Asıl Yazarlar: Mangen, Marie-Josée J., Rozenbaum, Mark H., Huijts, Susanne M., van Werkhoven, Cornelis H., Postma, Douwe F., Atwood, Mark, van Deursen, Anna M.M., van der Ende, Arie, Grobbee, Diederick E., Sanders, Elisabeth A.M., Sato, Reiko, Verheij, Theo J.M., Vissink, Conrad E., Bonten, Marc J.M., de Wit, G. Ardine
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: European Respiratory Society 2015
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4750466/
https://ncbi.nlm.nih.gov/pubmed/26160871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.00325-2015
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller